<DOC>
	<DOCNO>NCT00990314</DOCNO>
	<brief_summary>This open-label study patient participate BPS-MR-PAH-203 study volunteer continue treatment PAH Beraprost Sodium Modified Release ( BPS-MR ) tablet .</brief_summary>
	<brief_title>Extension BPS-MR-PAH-203 Pulmonary Arterial Hypertension ( PAH ) Patients</brief_title>
	<detailed_description>Eligible patient participate BPS-MR-PAH-203 elect continue receive study drug open-label extension.Each patient return clinic follow enrollment study 3 , 6 , 12 month , annually thereafter assessment . Patients call study personnel assess adverse event concomitant medication Month 9 , 3 month interval follow annual visit . At End Study visit , patient discontinue study drug down-titrated BPS-MR discretion Investigator , maximum decrement one tablet ( 60µg ) b.i.d . per day minimum decrement one tablet ( 60µg ) b.i.d . per week . Likewise , patient withdraw early study down-titrated BPS-MR manner . Upon completion down-titration , patient return clinic final Closeout visit . Currently enrol patient may invite participate optional four time daily ( QID ) dose substudy BPS-MR total daily dose BPS-MR achieve previously main study . Patients return clinic baseline visit , week 12 , follow visit schedule provide BPS-MR-PAH-204 main study .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Beraprost</mesh_term>
	<mesh_term>Epoprostenol</mesh_term>
	<criteria>Patients remain study drug complete assessment Treatment Phase Study BPS MR PAH 203 eligible study . Women childbearing potential ( define less 1 year postmenopausal surgically sterile ) must use acceptable method birth control practice abstinence . If sexually active , female patient must use double barrier method birth control , condom spermicidal . Patients discontinue study drug previous study ( BPS MR PAH 203 ) reason ( e.g . treatment related adverse event ) eligible entry study . Patients pregnant lactate excluded participation openlabel extension .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>